Produced in partnership with IBTV, our Roving Reporter series captures real-time perspectives from across the life sciences industry. Filmed on the floor at Terrapinn’s Advanced Therapies London 2026, this episode brings together leading voices from across cell and gene therapy to ask how shifting investment patterns are reshaping the advanced therapies sector – and what companies must do to build sustainable paths to patients.
Featuring insights from Ryan Cawood of LabThread, Raphael Ognar of NKILT Therapeutics, Nina Bauer of FUJIFILM Cellular Dynamics, Dominic Clarke of Cryoport Systems, Claudio Panzarella of ReiThera, Marianna Mainardi Koga of Bracco, Alexander Seyf of Autolomous, Ibon Garitaonandia of CellProthera, Natalia Elizalde of VIVEbiotech, Alan Griffith of VectorBuilder, Shrinidh Joshi of Cell Therapies Pty Ltd, Manuel Balbuena of eXmoor Pharma, and others, the discussion highlights how tighter capital is driving greater discipline across the field – with renewed emphasis on robust science, scalable manufacturing, cost control, strategic partnerships, and technologies that can demonstrate clear real-world value.
Watch the video below.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
